Israel - hebreo - Ministry of Health

medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 1000 iu - coagulation factor vii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 1500 iu - coagulation factor viii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 2000 iu - coagulation factor viii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 250 iu - coagulation factor vii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 3000 iu - coagulation factor viii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 500 iu - coagulation factor vii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - coagulation factor viii 750 iu - coagulation factor viii

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 1000 iu - coagulation factor ix

Israel - hebreo - Ministry of Health

sanofi - aventis israel ltd - coagulation factor ix (recombinant fc fusion protein –rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (recombinant fc fusion protein –rfixfc) 2000 iu - coagulation factor ix